All Sauce from Weekly Sauce:

Former pro football players with symptoms of depression or anxiety are far more likely to receive an unverifiable diagnosis of chronic traumatic encephalopathy (CTE) than players without those mental health conditions, a new study reports. Players with depression are 9.5 times more likely to be diagnosed with CTE, while players with both depression and anxiety…  read on >  read on >

FRIDAY, Oct. 6, 2023 (HealthDay News) – Postpartum depression is commonly thought of as something new moms experience, but fathers can also suffer from these feelings when entering this phase of life. A pilot study from the University of Illinois Chicago suggests new dads should also be screened for the condition. Addressing their health may…  read on >  read on >

FRIDAY, Oct. 6, 2023 (HealthDay News) – Healthy steps: Living in a neighborhood that’s easy to walk in could be good for women’s health. New research finds that women who live in walkable neighborhoods have lower rates of obesity-related cancers. This was particularly true of postmenopausal breast cancer, but also of ovarian cancer, endometrial cancer…  read on >  read on >

Should Fluffy and Fido go vegan? A new study says yes — for the environment. The United Nations Food and Agriculture Organization estimates that livestock are responsible for 14.5% of the greenhouse gas emissions. In response, some experts say eating vegan — meaning a nutritionally sound diet without animal proteins or products — for two-thirds…  read on >  read on >

Wallet-friendly cards showing proof of COVID vaccinations served a purpose early in the pandemic, but they’re on their way out. The U.S. Centers for Disease Control and Prevention has stopped printing the cards, likely changing how people track their shots in the future. The cards people have at home can still be used as proof…  read on >  read on >

While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects. Known as GLP-1 agonists, they may increase the risk of stomach paralysis, pancreatitis and bowel obstruction, scientists found. “Although the incidence of these adverse events are relatively rare,…  read on >  read on >